SCHEMBL4085582

SCHEMBL4085582

COc1cc(C(=O)c2cn(C(C)C)c3ncnc(N)c23)cc(NC(=O)Nc2ccccc2F)n1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 4/20 0.65
NTRK2 Q16620 3/20 0.65
NTRK3 Q16288 2/20 0.65
PDGFRB P09619 1/20 0.52
KCNH2 Q12809 3/20 0.51
PDPK1 O15530 8/20 0.47
RET P07949 4/20 0.44
LCK P06239 2/20 0.44
SRC P12931 2/20 0.44
EGFR P00533 2/20 0.43
ERBB2 P04626 2/20 0.43
ERBB3 P21860 2/20 0.43
TEK Q02763 2/20 0.43
ERBB4 Q15303 2/20 0.43
AKT1 P31749 4/20 0.41
MTOR P42345 4/20 0.41
EIF2AK3 Q9NZJ5 1/20 0.41
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4078414 0.90 NTRK1 (0.67) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4089407 0.86 NTRK1 (0.85) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4086058 0.85 NTRK1 (0.50) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1939776 0.85 NTRK1 (0.63) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4076616 0.82 NTRK1 (0.61) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941187 0.82 PDGFRB (0.75) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4080111 0.81 NTRK1 (0.64) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4080682 0.79 PDPK1 (0.55) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941135 0.79 NTRK1 (0.58) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL4081524 0.78 NTRK1 (1.00) NTRK1NTRK2NTRK3PDGFRBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595325-B2 Substituted pyrrolo[2,3-d]pyrimidine derivatives useful in cancer treatment PFIZER INC. (US) 2009-09-29 US disclosed